Natco Pharma Ltd.

Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, the 28th day of May 2025 to consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2025 and other items of business and related matters. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time-to-time TRADING WINDOW for dealing in the securities of the Company by the Employee(s), connected persons and their immediate relatives will be closed from 13th May, 2025 till 48 hours after the declaration of financial results.

The above information is a part of company’s filings submitted to BSE.